Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease

Objective: Pituitary adenylate-cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are two neuropeptides that exhibit anti-inflammatory and neuroprotective properties, modulating the production of cytokines and chemokines, and the behavior of immune cells. However, the rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shiyu, Huang, Shen, Ma, Jianjun, Li, Dongsheng, Zhao, Zhenxiang, Zheng, Jinhua, Li, Mingjian, Wang, Zhidong, Sun, Wenhua, Shi, Xiaoxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457255/
https://www.ncbi.nlm.nih.gov/pubmed/34566619
http://dx.doi.org/10.3389/fnagi.2021.689939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457255/
https://www.ncbi.nlm.nih.gov/pubmed/34566619
http://dx.doi.org/10.3389/fnagi.2021.689939

Ejemplares similares